The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
539561-BOM Key Metrics
539561-BOM Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
539561-BOM Share Price
539561-BOM
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
539561-BOM Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Negative
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
High and increasing Debt to Equity
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
539561-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
539561-BOM Bulk, Block & Insider Trades
539561-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Bonus
Rights issue
Stock split
Bonus(3 new shares for 1 existing shares) Ex-date: 5th Jul 2024 Announced on: 27th May 2024
Bonus(9 new shares for 5 existing shares) Ex-date: 28th Jul 2023 Announced on: 23rd Jun 2023
Rights issue(61 new shares @ 1 INR for 50 existing shares)"Rights ISIN INE549S20010SEDOL BT8TFK6." Ex-date: 15th Apr 2025 Announced on: 7th Apr 2025
Stock split(1 : 5)Nominal value change from INR 5 to INR 1. Ex-date: 23rd Feb 2024 Announced on: 8th Jan 2024
Stock split(1 : 2)Nominal value change from INR 10 to INR 5. Ex-date: 1st Sep 2023 Announced on: 23rd Jun 2023
Company Profile
Remedium Lifecare Limited is a pharmaceutical company, which is aligned across two business verticals, such as Products and Services. Products business comprises the trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovators and generic pharmaceutical players in bot... Read More
Key personnel
Mr. Ashish Dinanath Parkar
Chief Financial Officer
Mr. Kapil Goplani
Chief Compliance Officer, Company Secretary
Mr. Adarsh Deepak MunjalD
Whole Time Director
Mr. Hanosh Sam SantokD
Non-Executive Director
Ms. Trupti Madhukar BolkeD
Independent Director
Ms. Shamim Adil MichalD
Additional Independent Director
Mr. Vijay Pal Singh GulyaD
Additional Non-Executive Independent Director
Mr. Bikram Kumar MundD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Supha Pharmachem Ltd.?
The current share price of Supha Pharmachem Ltd. is ₹ 0.81 as of 09 Jan 2026.
What is the PE ratio of Supha Pharmachem Ltd.?
The Price-to-Earnings (PE) ratio of Supha Pharmachem Ltd. is 13.89 as of the latest financial data.
What is the ROE and ROCE of Supha Pharmachem Ltd.?
Supha Pharmachem Ltd. has a Return on Equity (ROE) of 4.90% and a Return on Capital Employed (ROCE) of -0.18% as per the latest financial reports.
What is the market cap of Supha Pharmachem Ltd.?
The market capitalization of Supha Pharmachem Ltd. stands at ₹ 71.44 Cr.
What is the dividend yield of Supha Pharmachem Ltd.?
The dividend yield of Supha Pharmachem Ltd. is 0.00% based on the current market price.
What is the RSI of Supha Pharmachem Ltd.?
The Relative Strength Index (RSI) of Supha Pharmachem Ltd. is 37.24.
What is the FII and DII holding in Supha Pharmachem Ltd.?
Foreign Institutional Investors (FII) hold 1.70% and Domestic Institutional Investors (DII) hold 0.00% of Supha Pharmachem Ltd. shares.
What sector does Supha Pharmachem Ltd. belong to?
Supha Pharmachem Ltd. operates in the Services sector.
What is the beta of Supha Pharmachem Ltd. stock?
The beta of Supha Pharmachem Ltd. stock is 0.15, indicating its volatility relative to the broader market.
